Current Status of Immunization Service Delivery in Africa Mary Harvey AFR/SD/HRD SOTA/PHN Meeting June 13, 2002.

Slides:



Advertisements
Similar presentations
Polio Communication Indicators Reflections from Polio Communication TAG/Review Process.
Advertisements

Diseases without borders What must the Global Development Community Do? World Bank Seminar Series Tawhid Nawaz, Operations Advisor Human Development Network.
Global Measles and Rubella Strategic Plan
Immunization Services DR. KANUPRIYA CHATURVEDI DR.S.K. CHATURVEDI.
Process and Recommendations. I. Introduction II. Process III. Key Achievement IV. Recommendations.
Dr. E. Anne Peterson, MD, MPH Assistant Administrator, Bureau for Global Health, USAID Sustainable Investment and Donor Coordination Stop TB Partners Forum.
Global Alliance for Vaccines and Immunization. WHAT IS GAVI ?
Critical conversations in Public-private partnerships Dr Ranjana Kumar 1 st November 2007.
1 Dr. Azhar Abid Raza Washington Sept 2011 Measles elimination in Pakistan.
Update on Vaccines not Included in this Tender: Rotavirus Vaccines Pre Tender Meeting UNICEF Supply Division, 10-11th December 2008 Ann Ottosen.
A REPRODUCTIVE HEALTH COMMODITY SECURITY STRATEGY FOR THE WEST AFRICA SUBREGION 2007 – 2011 Dr. Kabba Joiner, WAHO 2006 Fall Meeting of the Reproductive.
1 European Region Global Alliance for Vaccines & Immunization Overview on the Implementation Of the Introduction of New / Under-used Vaccines.
IPV IPV Rapidly produces high level of protective antibodies No risk of vaccine associated illness No interference from other enteroviruses. I.P.V. produces.
New Global Alliances  Global Alliance for Vaccines Initiative (GAVI)  Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria  STOP TB Initiative 
A global partnership to stop measles & rubella The Measles & Rubella Initiative: Preparing for the Next Decade Lisa Cairns, MD, MPH Sept 18, 2012 Washington,
Immunization and the Convention on the Rights of the Child What would it take to achieve universal coverage? Daniel Tarantola M.D. Professor of Health.
OIC-SHPA & Vaccines Need Assessment in OIC Member Countries
Global Health Program Guiding Principles April 2002.
Global Measles and Rubella Management Meeting Progress and Challenges in Bangladesh March, 2011 Geneva, WHO HQ Dr Serguei Diorditsa.
World Health Organization
Departmental Perspectives on Viral Hepatitis
Global Immunization Performance Update through 2011.
A Comprehensive Policy framework for the National Immunization Programme Dr Nihal Abeysinghe, [M.B.,B.S., MSc, M.D.] Chief Epidemiologist, Ministry of.
Creating a New Vision for Kentucky’s Youth Kentucky Youth Policy Assessment How can we Improve Services for Kentucky’s Youth? September 2005.
HRSA’s Oral Health Goals and the Role of MCH Stephen R. Smith Senior Advisor to the Administrator Health Resources and Services Administration.
Measles Initiative Financing February 28, 2007 Washington, D.C. Andrea Gay UN Foundation for Measles Partners.
Prevention and Control of Viral Hepatitis Infection: WHO Framework for Global Action Prevention and Control of Viral Hepatitis Infection: WHO Framework.
Progress towards Sustainable Measles Mortality Reduction South-East Asia Region Jayantha Liyanage Medical Officer- EPI Immunization and Vaccine Development.
What is “Reaching Every District” (RED) in Immunization? A brief overview Information from the global immunization partnership presented by Lora Shimp.
CRVS: Recent Progress. Global progress Advocacy  2013: ‘Convergence year’ for CRVS – many elements coming together, recognising the value is greater.
Expanded Program of Immunization Dr. Faten M. Rabie.
IMMUNIZATION IN UGANDA Dan Wamanya IMMUNIZATION IN UGANDA Dan Wamanya USAID/Uganda.
Outline Background Objectives and activities GPEI assets
5th Annual Advocacy Project: ImmuneWise Section on Medical Students, Residents, and Fellowship Trainees
Multi-Year Plans Strengthening immunization systems and introduction of hepatitis B vaccine in Central Europe and the Newly Independent States St. Petersburg,
Polio Eradication  Although the number of endemic countries is at an all-time low in 2002, the actual number of cases was approximately four times higher.
Edward J. Hoekstra, MD, MSc Edward J. Hoekstra, MD, MSc Senior Health Advisor Senior Health Advisor UNICEF HQ, New York UNICEF HQ, New York Peter Strebel,
1 Progress Towards Polio Eradication in EMR. 2 Status of global eradication Priority countries (except EMR) : Intensification : Certification,
Conclusions of the meeting and closing remarks. Chronology 1981Hepatitis B vaccine becomes available 1991World Health Assembly resolution call for the.
Global Overview Progress Towards Global Immunization Goals 21 st inter-country meeting of national managers of the Expanded Programme on Immunization Cairo,
JAHSR TECHNICAL REVIEW MEETING EPI Report Dr Dafrossa C Lyimo Programme Manager 7th September 2010 Dar es salaam.
1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.
Funding Update: 2013 – 2015 September 10,
WHO Regional Office for Europe Update on WHO GAVI European Regional Working Group and hepatitis B Immunization Viral Hepatitis Prevention Board Meeting.
Dr, Janbaz Afridi Deputy Director EPI Khyber Pakhtunkhwa
1 |1 | Measles pre-elimination and resurgence in the African region Balcha Masresha IVD AFRO Global Measles Management Meeting Geneva March 2011.
Status of EPI In Guinea DR. Mariama BAH Child Survival Advisor USAID/Guinea June 13, 2002.
WHO EURO In Country Coordination and Strengthening National Interagency Coordinating Committees.
Situation overview and Meeting Objectives The Middle East Polio Outbreak Phase II Review.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
Sudan EPI Benefits From Polio Eradication Program M&RI Annual Partners Meetings Washington D.C September 2015 Sudan EPI Benefits From Polio Eradication.
Update on Progress toward Measles Situation in EMR September 2008 Dr B. Naouri VPI/DCD/EMRO.
Child Survival and Disease Programs Fund Accounts, Guidance, and Coding March 12, 2001.
Measles Mortality Reduction: the risk of resurgence Global Immunization Meeting Geneva, Switzerland 1-3 February 2010 Balcha Masresha, WHO/AFRO.
A global partnership to stop measles & rubella 1 Measles & Rubella Initiative --Who We Are-- Stephen Cochi, MD, MPH Global Immunization Division Centers.
New Vaccine Introduction ‘MR vaccine introduction in Kenya’
Global Measles and Rubella: Highlights, Priorities and Critical Issues
World Health Organization
World Health Organization
Global Overview of Measles
Measles & Rubella Initiative Partners meeting September 7-8, 2017
POLIOPLUS FACT SHEET Feb 2018
Progress and Challenges with achieving Universal Immunization Coverage
World Health Organization
Stakeholder Consultation
State of Measles Initiative Financing Partners for Measles Advocacy Meeting Washington, D.C. September 22, 2008 Andrea Gay.
Partners for Measles Advocacy—7th Annual Meeting
YELLOW FEVER VACCINE AVAILABILITY AND NEEDS FOR THE AFRICAN REGION
Dr Timothy Armstrong Coordinator
Developing a Financial Sustainability Plan for Cambodia
Presentation transcript:

Current Status of Immunization Service Delivery in Africa Mary Harvey AFR/SD/HRD SOTA/PHN Meeting June 13, 2002

Nearly one million vaccine preventable deaths occurring annually in the Region Measles Hib Hepatitis B related diseases 150,000 Pertussis MNT110,000 Yellow Fever20,000-30,000 Meningococcal diseases30,000-50,000

Reported DTP3 Coverage by Epidemiological Block Africa Region, 1994 – 2000 Special Sit.

Measles coverage, Selected Countries,

DPT3 Coverage, Selected Countries,

Take Home Message USAID Support is important/Essential Support includes Technical Assistance for Routine EPI Advocacy and TA for Cost-Effective Interventions Management of Health Sector Reforms Strengthened Partnerships/ICCs

Changing Environment of EPI

Disease Control Initiatives Polio Eradication Measles Control/Elimination Neo-Natal Tetanus Elimination

Polio Funding Trends by Region Sources: USAID Bureau of Global Health and Polio Eradication Initiative Total Funding Amount = $164,398,302

Polio Eradication : progress made # of polio endemic countries AFP cases Reported Wild polio viruses confirmed

Progress and Plan to Eradicate Polio Source: World Health Organization, April 24, 2001 Surveillance acceleration begins Revised target: Poliovirus transmission interrupted by Dec Earliest estimated date for global certification: 2005 Earliest estimated date for stopping immunization: 2010

Wild Poliovirus Cases, , WHO/Africa Region Jan-Dec 2000 AFRO/ Data up to 30 November, 2001 Jan-Dec 1999 Jan-Dec 2001

Proposed Revisions – May 20 USAID PEI Results Framework Stabilize World Population and Protect Human Health in a Sustainable Fashion Stabilize World Population and Protect Human Health in a Sustainable Fashion Agency Goal USAID-PEI Strategic Objective: Global Polio Eradication USAID-PEI Strategic Objective: Global Polio Eradication Critical Assumptions: — USAID supports the World Health Assembly resolution on global polio eradication — Successful global eradication depends upon continued support from all partners — Polio immunization can one day be stopped — Transmission of poliovirus can be interrupted — Polio-related activities will continue until 2010 Selected immunization support systems, at the national and sub-national levels in the public and private sectors, strengthened to achieve and maintain polio eradication Improved quality, detailed and timely planning and implementation for supplemental polio immunization (including NIDs, SNIDs, mopping up) and, when appropriate, other interventions or vaccines Improved Acute Flaccid Paralysis (AFP) surveillance and response system that is integrated with surveillance for other infectious diseases Timely documentation and use of information to continuously improve the quality of polio eradication immunization and VPD-control activities Build Effective Partnerships Strengthen Selected Systems Support Supplemental Immunization Improve Surveillance Improve Information Collection and Use First-level Results Support the global eradication of polio and related actions to maintain immunity by the year 2007, in selected countries and regions, in ways that contribute to the development of sustainable immunization and disease control programs Effective partnerships to support the implementation of polio eradication, immunization, and vaccine preventable disease-(VPD) control programs established and operational Note: Italics represent proposed revised language.

Take Home Messages Maintain Heads of States and Health Ministers involvment-We are close to achieving the goal but the work is not yet done anywhere in Africa! NIDS will need to continue every two to three years after 2005 and polio eradication has been certified, IF ROUTINE COVERAGE for polio 3 is less than 90% Document experiences of implementation of district performance contracts and potentials for other health interventions Strengthen sub-regional EPI coordinating structures (bi- laterals, rotating chairmanship) Use infrastructure built for polio eradication to expand support to other disease control activities

Measles Mortality Reduction WHO/UNICEF Goals Reduce the number of measles deaths by half by 2005 Achieve and maintain interruption of indigenous measles transmission in large geographical areas with established elimination goals Review progress in 2005 with other partners

Recommended Strategies Providing the first dose of measles vaccine to successive cohorts of infants ensuring that all children have a second opportunity for measles vaccination enhancing measles surveillance with integration of epidemiological and laboratory information improving the management of every measles case including vitamin A supplementation.

Take Home Messages USAID recognizes that measles causes significant morbidity and mortality Based on the data, USAID strongly supports intensified efforts to reduce measles transmission and disease burden USAID supports a balanced and comprehensive approach to effective measles control, which is consistent with and contributes to delivery of primary health care services.

MNT Elimination: Attaining a true rate of NT <1/1000 live birth/year/district Strategies for attaining elimination TT Supplemental immunization activities in high risk areas with  80% coverage in CBAW Clean delivery practices of  70% Active surveillance for NT

Countries’ MNT Elimination Status in the African Region Countries’ MNT Elimination Status in the African Region Potentialité Eliminated NT near Elimination With POAs No POAs

Other Initiatives GAVI

The Global Alliance for Vaccines and Immunization Mission: “ To save children’s lives and protect people’s health through the widespread use of vaccines”

Status of GAVI/VF Support, African Region (Sept 01)

GAVI at the National Level Concepts –Coordination among all partners supporting immunization (ICC or other)- ICC has additional role to play –Focus support on consolidated national 5 year plan and annual workplans –Monitoring and evaluation through shared instruments –Support and intra-country coordination available through Regional Working Groups

GAVI At The National Level Upcoming areas of attention –Completion of application for available support –Support for implementation of national annual plans (participation in ICC and provision of TA) –Data Quality audits - improved district level reporting –Enhanced financial planning & completion of Financial Sustainability Plans

CountriesActivities fundedObservations MALI ($429,000 in Jan 01) Microplanning workshop Funds for EPI operations for 13 districts District microplans approved by ICC Performance contract signed with districts GHANA ($265,400 in Dec 00) Procurement of motor bikes, copiers Training / microplanning /data management VF for infrastructure and not recurrent costs Checks through Audit GAVI/VF have already reached the districts : a critical factor for success

CHALLENGES Maintain all partner commitments to EPI in the Region HIGH on their Agenda. Keep Countries commitment to EPI and maintain a significant funding for EPI from national Budget It is difficult to get all partners working together, but there is no better way way to succeed Take Home Messages

CHALLENGES USAID should nurture the development of Competent and Functional ICCs to Support EPI and its MYIP: Participate in the ICC, Support, Monitoring and Evaluation activities. Respond to increasing demand for Technical Assistance in Countries Encourage support for improving safety of injections and encourage timely introduction of HepB, Hib and Yellow Fever Vaccination Take Home Messages